A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) +/- two cycles of EP (etoposide + cisplatin) in node positive patients with breast cancer. [electronic resource]
Producer: 20020205Description: 1011-3 p. digitalISSN:- 0923-7534
- Adult
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Axilla
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Humans
- Lymphatic Metastasis
- Middle Aged
- Premenopause
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.